Business
Press Release Aug 07 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 05, 2023, titled "Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride forInjection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose Vials".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 05, 2023, titled \"Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride forInjection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose Vials\". View Attachment","length":425,"tagName":"div"}]